Literature DB >> 8432131

Hypoxemia during altitude exposure. A meta-analysis of chronic obstructive pulmonary disease.

T A Dillard1, A P Rosenberg, B W Berg.   

Abstract

A previous study identified spirometric testing as a useful adjunct for estimating PaO2 during altitude exposure in patients with chronic obstructive pulmonary disease (COPD). We sought to examine the validity of this finding by quantitative analysis of recent published reports. We analyzed acute hypoxic exposures from five prior studies involving 71 patients. Across all studies, the change in arterial oxygen tension per unit change in inspired oxygen partial pressure (linear slope, dPaO2/dP1O2) correlated with the preexposure forced expiratory volume in 1 s (FEV1, p < 0.01). The correlation with FEV1 held for values weighted or unweighted by sample size, with rotating deletion of each study from analysis one at a time, and with semilog slope as the dependent variable. A formula derived from the semilog slope relationship with FEV1 gave accurate description of the mean hypoxic response in each prior study and individual responses from one study (n = 18): ln (PaO2alt/PaO2g) = Kn.(PIO2alt-PIO2g). We found that FEV1 modulated the values of kn in this study. We conclude, based on analysis of prior studies, that preexposure arterial oxygen tension and FEV1 both influence the prediction of PaO2 during hypoxic exposures in patients with COPD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432131     DOI: 10.1378/chest.103.2.422

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

Review 1.  Holidays and cystic fibrosis.

Authors:  A Verma; M E Dodd; C S Haworth; A K Webb
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations.

Authors: 
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

3.  Predicting hypoxaemia during flights in children with cystic fibrosis.

Authors:  R M Buchdahl; A Babiker; A Bush; D Cramer
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

4.  Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension.

Authors:  Nareg Roubinian; C Gregory Elliott; Christopher F Barnett; Paul D Blanc; Joan Chen; Teresa De Marco; Hubert Chen
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

Review 5.  Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment.

Authors:  Kirsten Holthof; Pierre-Olivier Bridevaux; Isabelle Frésard
Journal:  BMC Pulm Med       Date:  2022-05-09       Impact factor: 3.320

6. 

Authors:  Francisco Ríos Tejada
Journal:  FMC       Date:  2009-01-06

Review 7.  [Air travel and respiratory diseases].

Authors:  Francisco García Río; Luis Borderías Clau; Ciro Casanova Macario; Bartolomé R Celli; Joan Escarrabill Sanglás; Nicolás González Mangado; Josep Roca Torrent; Fernando Uresandi Romero
Journal:  Arch Bronconeumol       Date:  2007-02       Impact factor: 4.872

8.  Predicting the need for supplemental oxygen during airline flight in patients with chronic pulmonary disease: a comparison of predictive equations and altitude simulation.

Authors:  Ana C Bradi; Marie E Faughnan; Matthew B Stanbrook; Eva Deschenes-Leek; Kenneth R Chapman
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

Review 9.  Chronic obstructive pulmonary disease * 11: fitness to fly with COPD.

Authors:  A O C Johnson
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

10.  Respiratory function and blood gas variables in cystic fibrosis patients during reduced environmental pressure.

Authors:  Oliver Thews; Birthe Fleck; Wolfgang E S Kamin; Dirk-Matthias Rose
Journal:  Eur J Appl Physiol       Date:  2004-08       Impact factor: 3.078

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.